|
US3766774A
(en)
|
1972-02-18 |
1973-10-23 |
H Clark |
Apparatus and method for measuring blood characteristics
|
|
US4270537A
(en)
*
|
1979-11-19 |
1981-06-02 |
Romaine Richard A |
Automatic hypodermic syringe
|
|
US4446122A
(en)
*
|
1979-12-28 |
1984-05-01 |
Research Corporation |
Purified human prostate antigen
|
|
USRE33405E
(en)
|
1979-12-28 |
1990-10-23 |
Research Corporation Technologies, Inc. |
Purified human prostate antigen
|
|
US4946929A
(en)
|
1983-03-22 |
1990-08-07 |
Massachusetts Institute Of Technology |
Bioerodible articles useful as implants and prostheses having predictable degradation rates
|
|
US4818542A
(en)
|
1983-11-14 |
1989-04-04 |
The University Of Kentucky Research Foundation |
Porous microspheres for drug delivery and methods for making same
|
|
US4795436A
(en)
|
1983-11-14 |
1989-01-03 |
Bio-Mimetics, Inc. |
Bioadhesive composition and method of treatment therewith
|
|
US4638045A
(en)
*
|
1985-02-19 |
1987-01-20 |
Massachusetts Institute Of Technology |
Non-peptide polyamino acid bioerodible polymers
|
|
US4596556A
(en)
*
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
US4631211A
(en)
|
1985-03-25 |
1986-12-23 |
Scripps Clinic & Research Foundation |
Means for sequential solid phase organic synthesis and methods using the same
|
|
GB8601100D0
(en)
|
1986-01-17 |
1986-02-19 |
Cosmas Damian Ltd |
Drug delivery system
|
|
US4806621A
(en)
*
|
1986-01-21 |
1989-02-21 |
Massachusetts Institute Of Technology |
Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article
|
|
US4970299A
(en)
|
1986-07-03 |
1990-11-13 |
Sloan-Kettering Institute For Cancer Research |
Monoclonal antibodies selective for prostate cancer
|
|
US5075109A
(en)
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
|
US6024983A
(en)
|
1986-10-24 |
2000-02-15 |
Southern Research Institute |
Composition for delivering bioactive agents for immune response and its preparation
|
|
CA1340581C
(en)
*
|
1986-11-20 |
1999-06-08 |
Joseph P. Vacanti |
Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
|
|
US5736372A
(en)
*
|
1986-11-20 |
1998-04-07 |
Massachusetts Institute Of Technology |
Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
|
|
US5804178A
(en)
|
1986-11-20 |
1998-09-08 |
Massachusetts Institute Of Technology |
Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue
|
|
US4987071A
(en)
|
1986-12-03 |
1991-01-22 |
University Patents, Inc. |
RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
|
|
US5116742A
(en)
|
1986-12-03 |
1992-05-26 |
University Patents, Inc. |
RNA ribozyme restriction endoribonucleases and methods
|
|
US4886499A
(en)
|
1986-12-18 |
1989-12-12 |
Hoffmann-La Roche Inc. |
Portable injection appliance
|
|
FR2608988B1
(fr)
*
|
1986-12-31 |
1991-01-11 |
Centre Nat Rech Scient |
Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
|
|
GB8704027D0
(en)
*
|
1987-02-20 |
1987-03-25 |
Owen Mumford Ltd |
Syringe needle combination
|
|
US4903649A
(en)
|
1987-03-12 |
1990-02-27 |
Brunswick Corporation |
Fuel supply system with pneumatic amplifier
|
|
US4902615A
(en)
*
|
1987-03-27 |
1990-02-20 |
Biosciences Corporation Of Texas |
Detection of human cancer cells with antibodies to human cancer nucleolar antigen p120
|
|
DE3812289C2
(de)
|
1987-04-20 |
1995-06-08 |
Mitsubishi Electric Corp |
Leerlaufdrehzahlregelvorrichtung für eine Brennkraftmaschine
|
|
US4839416A
(en)
|
1987-06-09 |
1989-06-13 |
Ampad Corporation |
Low tack microsphere adhesive
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US5069936A
(en)
|
1987-06-25 |
1991-12-03 |
Yen Richard C K |
Manufacturing protein microspheres
|
|
US5019379A
(en)
*
|
1987-07-31 |
1991-05-28 |
Massachusetts Institute Of Technology |
Unsaturated polyanhydrides
|
|
US5200181A
(en)
|
1988-01-11 |
1993-04-06 |
Massachusetts Institute Of Technology |
Oral bilirubin therapy
|
|
US5339163A
(en)
|
1988-03-16 |
1994-08-16 |
Canon Kabushiki Kaisha |
Automatic exposure control device using plural image plane detection areas
|
|
US5162504A
(en)
|
1988-06-03 |
1992-11-10 |
Cytogen Corporation |
Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients
|
|
JPH0249596A
(ja)
|
1988-08-09 |
1990-02-19 |
Masamichi Ueda |
ヒト前立腺上皮細胞の表面に特異的に反応するモノクローナル抗体
|
|
US4959219A
(en)
|
1988-08-15 |
1990-09-25 |
Fisons Corporation |
Coating barriers comprising ethyl cellulose
|
|
FR2638359A1
(fr)
|
1988-11-03 |
1990-05-04 |
Tino Dalto |
Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
|
|
WO1990006430A1
(en)
|
1988-12-09 |
1990-06-14 |
Robert Bosch Gmbh |
Method for acceleration enrichment in fuel injection systems
|
|
US5334497A
(en)
|
1988-12-13 |
1994-08-02 |
Hideki Inaba |
Method of feeding a substrate into tubular bioreactor
|
|
US4976968A
(en)
|
1989-02-24 |
1990-12-11 |
Clinical Technologies Associates, Inc. |
Anhydrous delivery systems for pharmacological agents
|
|
US5010167A
(en)
*
|
1989-03-31 |
1991-04-23 |
Massachusetts Institute Of Technology |
Poly(amide-and imide-co-anhydride) for biological application
|
|
EP0499619B1
(en)
|
1989-11-06 |
1996-02-07 |
Alkermes Controlled Therapeutics, Inc. |
Method for producing protein microspheres
|
|
AU642932B2
(en)
|
1989-11-06 |
1993-11-04 |
Alkermes Controlled Therapeutics, Inc. |
Protein microspheres and methods of using them
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5312335A
(en)
*
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US6399754B1
(en)
*
|
1991-12-24 |
2002-06-04 |
Isis Pharmaceuticals, Inc. |
Sugar modified oligonucleotides
|
|
US6005087A
(en)
|
1995-06-06 |
1999-12-21 |
Isis Pharmaceuticals, Inc. |
2'-modified oligonucleotides
|
|
US5240963A
(en)
|
1990-01-19 |
1993-08-31 |
Nova Pharmaceutical Corporation |
Branched polyanhydrides
|
|
US6001577A
(en)
|
1998-06-08 |
1999-12-14 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
|
|
US5763177A
(en)
*
|
1990-06-11 |
1998-06-09 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
|
|
US6716580B2
(en)
*
|
1990-06-11 |
2004-04-06 |
Somalogic, Inc. |
Method for the automated generation of nucleic acid ligands
|
|
US5853984A
(en)
|
1990-06-11 |
1998-12-29 |
Nexstar Pharmaceuticals, Inc. |
Use of nucleic acid ligands in flow cytometry
|
|
KR970002255B1
(ko)
|
1990-06-11 |
1997-02-26 |
넥스스타 파아마슈티컬드, 인크. |
핵산 리간드
|
|
US5496938A
(en)
*
|
1990-06-11 |
1996-03-05 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands to HIV-RT and HIV-1 rev
|
|
US6280932B1
(en)
*
|
1990-06-11 |
2001-08-28 |
Gilead Sciences, Inc. |
High affinity nucleic acid ligands to lectins
|
|
US5874218A
(en)
*
|
1990-06-11 |
1999-02-23 |
Nexstar Pharmaceuticals, Inc. |
Method for detecting a target compound in a substance using a nucleic acid ligand
|
|
US5270163A
(en)
|
1990-06-11 |
1993-12-14 |
University Research Corporation |
Methods for identifying nucleic acid ligands
|
|
US5567588A
(en)
|
1990-06-11 |
1996-10-22 |
University Research Corporation |
Systematic evolution of ligands by exponential enrichment: Solution SELEX
|
|
US5660985A
(en)
|
1990-06-11 |
1997-08-26 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands containing modified nucleotides
|
|
US5789163A
(en)
|
1990-06-11 |
1998-08-04 |
Nexstar Pharmaceuticals, Inc. |
Enzyme linked oligonucleotide assays (ELONAS)
|
|
US6699474B1
(en)
|
1990-08-20 |
2004-03-02 |
Erich Hugo Cerny |
Vaccine and immunserum against drugs of abuse
|
|
US5190521A
(en)
*
|
1990-08-22 |
1993-03-02 |
Tecnol Medical Products, Inc. |
Apparatus and method for raising a skin wheal and anesthetizing skin
|
|
US5527288A
(en)
*
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
|
US5389640A
(en)
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
US5175296A
(en)
|
1991-03-01 |
1992-12-29 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-c]quinolin-4-amines and processes for their preparation
|
|
US5403750A
(en)
|
1991-03-06 |
1995-04-04 |
W. R. Grace & Co.-Conn. |
Biocompatible, low protein adsorption affinity matrix
|
|
IT1250421B
(it)
|
1991-05-30 |
1995-04-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
|
|
US5766635A
(en)
|
1991-06-28 |
1998-06-16 |
Rhone-Poulenc Rorer S.A. |
Process for preparing nanoparticles
|
|
GB9118204D0
(en)
*
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
|
SE9102652D0
(sv)
*
|
1991-09-13 |
1991-09-13 |
Kabi Pharmacia Ab |
Injection needle arrangement
|
|
US5811447A
(en)
*
|
1993-01-28 |
1998-09-22 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US5328483A
(en)
|
1992-02-27 |
1994-07-12 |
Jacoby Richard M |
Intradermal injection device with medication and needle guard
|
|
IL105325A
(en)
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
|
US6197346B1
(en)
|
1992-04-24 |
2001-03-06 |
Brown Universtiy Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
|
US6235313B1
(en)
|
1992-04-24 |
2001-05-22 |
Brown University Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
|
US5383851A
(en)
*
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
KR940003548U
(ko)
|
1992-08-14 |
1994-02-21 |
김형술 |
세탁물 건조기
|
|
US6608201B2
(en)
|
1992-08-28 |
2003-08-19 |
3M Innovative Properties Company |
Process for preparing 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
FR2695563B1
(fr)
|
1992-09-11 |
1994-12-02 |
Pasteur Institut |
Microparticules portant des antigènes et leur utilisation pour l'induction de réponses humorales ou cellulaires.
|
|
US5569189A
(en)
*
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
|
US5334144A
(en)
|
1992-10-30 |
1994-08-02 |
Becton, Dickinson And Company |
Single use disposable needleless injector
|
|
US5399665A
(en)
*
|
1992-11-05 |
1995-03-21 |
Massachusetts Institute Of Technology |
Biodegradable polymers for cell transplantation
|
|
WO1994015635A1
(en)
|
1993-01-11 |
1994-07-21 |
Dana-Farber Cancer Institute |
Inducing cytotoxic t lymphocyte responses
|
|
US5512600A
(en)
|
1993-01-15 |
1996-04-30 |
Massachusetts Institute Of Technology |
Preparation of bonded fiber structures for cell implantation
|
|
US5514378A
(en)
*
|
1993-02-01 |
1996-05-07 |
Massachusetts Institute Of Technology |
Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
|
|
US5820879A
(en)
|
1993-02-12 |
1998-10-13 |
Access Pharmaceuticals, Inc. |
Method of delivering a lipid-coated condensed-phase microparticle composition
|
|
US5916539A
(en)
*
|
1993-03-02 |
1999-06-29 |
Silica Gel Ges. M.B.H. |
Superparamagnetic particles, process for producing the same and their use
|
|
US5342781A
(en)
|
1993-07-15 |
1994-08-30 |
Su Wei Wen W |
External-loop perfusion air-lift bioreactor
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
|
US5744155A
(en)
|
1993-08-13 |
1998-04-28 |
Friedman; Doron |
Bioadhesive emulsion preparations for enhanced drug delivery
|
|
US5798340A
(en)
*
|
1993-09-17 |
1998-08-25 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
|
US6458539B1
(en)
|
1993-09-17 |
2002-10-01 |
Somalogic, Inc. |
Photoselection of nucleic acid ligands
|
|
US5500161A
(en)
*
|
1993-09-21 |
1996-03-19 |
Massachusetts Institute Of Technology And Virus Research Institute |
Method for making hydrophobic polymeric microparticles
|
|
WO1995024176A1
(en)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Ampule filling device
|
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
|
US5596091A
(en)
*
|
1994-03-18 |
1997-01-21 |
The Regents Of The University Of California |
Antisense oligonucleotides comprising 5-aminoalkyl pyrimidine nucleotides
|
|
GB9412273D0
(en)
|
1994-06-18 |
1994-08-10 |
Univ Nottingham |
Administration means
|
|
US6007845A
(en)
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
|
US5716404A
(en)
*
|
1994-12-16 |
1998-02-10 |
Massachusetts Institute Of Technology |
Breast tissue engineering
|
|
US5599302A
(en)
*
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
|
US6030613A
(en)
|
1995-01-17 |
2000-02-29 |
The Brigham And Women's Hospital, Inc. |
Receptor specific transepithelial transport of therapeutics
|
|
US5786204A
(en)
|
1995-01-20 |
1998-07-28 |
Human Genome Sciences, Inc. |
Human prostatic specific reductase
|
|
US5686113A
(en)
|
1995-03-21 |
1997-11-11 |
Temple University Of The Commonwealth System Of Higher Education |
Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses
|
|
US5876727A
(en)
|
1995-03-31 |
1999-03-02 |
Immulogic Pharmaceutical Corporation |
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
|
|
US6123727A
(en)
|
1995-05-01 |
2000-09-26 |
Massachusetts Institute Of Technology |
Tissue engineered tendons and ligaments
|
|
US6902743B1
(en)
|
1995-05-22 |
2005-06-07 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
|
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
US20020150578A1
(en)
|
1995-06-05 |
2002-10-17 |
Human Genome Sciences, Inc. |
Human prostatic specific reductase
|
|
US5843732A
(en)
|
1995-06-06 |
1998-12-01 |
Nexstar Pharmaceuticals, Inc. |
Method and apparatus for determining consensus secondary structures for nucleic acid sequences
|
|
US5879712A
(en)
|
1995-06-07 |
1999-03-09 |
Sri International |
Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
|
|
US7422902B1
(en)
|
1995-06-07 |
2008-09-09 |
The University Of British Columbia |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
|
WO1997004747A1
(en)
|
1995-07-27 |
1997-02-13 |
Dunn James M |
Drug delivery systems for macromolecular drugs
|
|
US6096344A
(en)
|
1995-07-28 |
2000-08-01 |
Advanced Polymer Systems, Inc. |
Bioerodible porous compositions
|
|
US6395770B1
(en)
|
1995-10-26 |
2002-05-28 |
Baker Norton Pharmaceuticals, Inc. |
Method and compositions for administering taxanes orally to human patients
|
|
US6095148A
(en)
|
1995-11-03 |
2000-08-01 |
Children's Medical Center Corporation |
Neuronal stimulation using electrically conducting polymers
|
|
FR2742357B1
(fr)
|
1995-12-19 |
1998-01-09 |
Rhone Poulenc Rorer Sa |
Nanoparticules stabilisees et filtrables dans des conditions steriles
|
|
US5893397A
(en)
*
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
|
US5902599A
(en)
*
|
1996-02-20 |
1999-05-11 |
Massachusetts Institute Of Technology |
Biodegradable polymer networks for use in orthopedic and dental applications
|
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
|
US6136311A
(en)
*
|
1996-05-06 |
2000-10-24 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of cancer
|
|
US5898031A
(en)
|
1996-06-06 |
1999-04-27 |
Isis Pharmaceuticals, Inc. |
Oligoribonucleotides for cleaving RNA
|
|
US20020106647A1
(en)
|
1996-07-24 |
2002-08-08 |
Segal Andrew H. |
Nucleic acid compositions and methods of introducing nucleic acids into cells
|
|
US5922695A
(en)
|
1996-07-26 |
1999-07-13 |
Gilead Sciences, Inc. |
Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
|
|
JP2001504448A
(ja)
|
1996-08-30 |
2001-04-03 |
フュルステ，イェンス，ペーター |
核酸の鏡面対称選択および進化
|
|
EP1006798A4
(en)
|
1996-09-05 |
2003-03-05 |
Massachusetts Inst Technology |
COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS AND NEURODEGENERATIVE DISEASES
|
|
US6368598B1
(en)
*
|
1996-09-16 |
2002-04-09 |
Jcrt Radiation Oncology Support Services, Inc. |
Drug complex for treatment of metastatic prostate cancer
|
|
US6120666A
(en)
|
1996-09-26 |
2000-09-19 |
Ut-Battelle, Llc |
Microfabricated device and method for multiplexed electrokinetic focusing of fluid streams and a transport cytometry method using same
|
|
CZ294563B6
(cs)
|
1996-10-25 |
2005-02-16 |
Minnesota Mining And Manufacturing Company |
Sloučeniny představující modifikátory imunitní odezvy při léčení nemocí mediovaných TH2 buňkami a nemocí odvozených
|
|
US7205437B2
(en)
|
1996-11-27 |
2007-04-17 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators
|
|
US6995284B2
(en)
*
|
2000-08-24 |
2006-02-07 |
The University Of Tennessee Research Foundation |
Synthesis of selective androgen receptor modulators
|
|
US7759520B2
(en)
*
|
1996-11-27 |
2010-07-20 |
University Of Tennessee Research Foundation |
Synthesis of selective androgen receptor modulators
|
|
US7518013B2
(en)
|
2000-08-24 |
2009-04-14 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators
|
|
US6127533A
(en)
|
1997-02-14 |
2000-10-03 |
Isis Pharmaceuticals, Inc. |
2'-O-aminooxy-modified oligonucleotides
|
|
EP1019071A4
(en)
|
1997-05-15 |
2003-07-30 |
Cytogen Corp |
Arbitrary peptides which transport receptors of the gastro-intestinal tract bind and process with it
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
GB9713980D0
(en)
|
1997-07-03 |
1997-09-10 |
Danbiosyst Uk |
New conjugates
|
|
US5837752A
(en)
|
1997-07-17 |
1998-11-17 |
Massachusetts Institute Of Technology |
Semi-interpenetrating polymer networks
|
|
US6190913B1
(en)
|
1997-08-12 |
2001-02-20 |
Vijay Singh |
Method for culturing cells using wave-induced agitation
|
|
US7001996B1
(en)
|
1997-08-21 |
2006-02-21 |
The United States Of America As Represented By The Secretary Of The Army |
Enzymatic template polymerization
|
|
US6451527B1
(en)
|
1997-08-29 |
2002-09-17 |
Selective Genetics, Inc. |
Methods using genetic package display for selecting internalizing ligands for gene delivery
|
|
US20040136961A1
(en)
|
1997-10-09 |
2004-07-15 |
Ales Prokop |
Nanoparticulate composition for efficient gene transfer
|
|
DE19745950A1
(de)
|
1997-10-17 |
1999-04-22 |
Dds Drug Delivery Service Ges |
Arzneistoffträgerpartikel für die gewebespezifische Arzneistoffapplikation
|
|
EP1029048A2
(en)
*
|
1997-11-05 |
2000-08-23 |
Baylor College Of Medicine |
Sequences for targeting metastatic cells
|
|
US6254890B1
(en)
|
1997-12-12 |
2001-07-03 |
Massachusetts Institute Of Technology |
Sub-100nm biodegradable polymer spheres capable of transporting and releasing nucleic acids
|
|
US6242246B1
(en)
*
|
1997-12-15 |
2001-06-05 |
Somalogic, Inc. |
Nucleic acid ligand diagnostic Biochip
|
|
US6506559B1
(en)
*
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
|
US6506577B1
(en)
*
|
1998-03-19 |
2003-01-14 |
The Regents Of The University Of California |
Synthesis and crosslinking of catechol containing copolypeptides
|
|
US6686446B2
(en)
*
|
1998-03-19 |
2004-02-03 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
US6632922B1
(en)
|
1998-03-19 |
2003-10-14 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
AU760669B2
(en)
*
|
1998-04-28 |
2003-05-22 |
Galenica Pharmaceuticals, Inc. |
Polysaccharide-antigen conjugates
|
|
SE9801923D0
(sv)
|
1998-05-29 |
1998-05-29 |
Independent Pharmaceutical Ab |
Nicotine vaccine
|
|
DE19827164A1
(de)
*
|
1998-06-18 |
1999-12-23 |
Merck Patent Gmbh |
Katalytisch Titan(IV)-oxid vermittelte geminale symmetrische Dialkylierung von Carbonsäureamiden
|
|
US6265608B1
(en)
|
1998-06-30 |
2001-07-24 |
Eastman Chemical Company |
Method of purifying aromatic dicarboxylic acids
|
|
US6395718B1
(en)
|
1998-07-06 |
2002-05-28 |
Guilford Pharmaceuticals Inc. |
Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors
|
|
US6429200B1
(en)
|
1998-07-17 |
2002-08-06 |
Mirus Corporation |
Reverse micelles for delivery of nucleic acids
|
|
DE19839214C1
(de)
|
1998-08-28 |
2000-05-25 |
Aventis Res & Tech Gmbh & Co |
Verfahren zur Herstellung von sphärischen Mikropartikeln mit glatter Oberfläche, die ganz oder teilweise aus mindestens einem wasserunlöslichen linearen Polysaccharid bestehen, sowie mit diesem Verfahren erhältliche Mikropartikel und deren Verwendung
|
|
DE69918146T2
(de)
|
1998-10-05 |
2005-07-07 |
Pharmexa A/S |
Verfahren zur therapeutischen impfung
|
|
AU6419899A
(en)
|
1998-10-09 |
2000-05-01 |
Regents Of The University Of Michigan, The |
Hydrogels and water soluble polymeric carriers for drug delivery
|
|
US6428814B1
(en)
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
US6232082B1
(en)
|
1998-12-01 |
2001-05-15 |
Nabi |
Hapten-carrier conjugates for treating and preventing nicotine addiction
|
|
SK287112B6
(sk)
|
1999-01-08 |
2009-12-07 |
3M Innovative Properties Company |
Použitie zlúčeniny modifikujúcej imunitnú odpoveď pri liečení cervikálnej dysplázie
|
|
US6403779B1
(en)
*
|
1999-01-08 |
2002-06-11 |
Isis Pharmaceuticals, Inc. |
Regioselective synthesis of 2′-O-modified nucleosides
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
US20030054360A1
(en)
*
|
1999-01-19 |
2003-03-20 |
Larry Gold |
Method and apparatus for the automated generation of nucleic acid ligands
|
|
DE19956568A1
(de)
|
1999-01-30 |
2000-08-17 |
Roland Kreutzer |
Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
|
|
JP2002536640A
(ja)
|
1999-02-03 |
2002-10-29 |
アクララ バイオサイエンシーズ， インコーポレイテッド |
微小流体導入の際のマルチチャネル制御
|
|
US6558951B1
(en)
|
1999-02-11 |
2003-05-06 |
3M Innovative Properties Company |
Maturation of dendritic cells with immune response modifying compounds
|
|
US6110462A
(en)
|
1999-03-03 |
2000-08-29 |
The Scripps Research Institute |
Enzymatic DNA molecules that contain modified nucleotides
|
|
GB9905136D0
(en)
|
1999-03-06 |
1999-04-28 |
Danbiosyst Uk |
Surface modification of lamellar particles
|
|
US6943235B1
(en)
*
|
1999-04-12 |
2005-09-13 |
Agensys, Inc. |
Transmembrane protein expressed in prostate cancer
|
|
US6528499B1
(en)
|
2000-04-27 |
2003-03-04 |
Georgetown University |
Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
|
|
US20020102613A1
(en)
|
1999-05-18 |
2002-08-01 |
Hoogenboom Hendricus Renerus Jacobus Mattheus |
Novel Fab fragment libraries and methods for their use
|
|
DK1409654T3
(da)
|
1999-06-16 |
2008-12-08 |
Boston Biomedical Res Inst |
Immunologisk styring af beta-amyloid-niveauer in vivo
|
|
US6506887B1
(en)
*
|
1999-07-29 |
2003-01-14 |
Somalogic, Incorporated |
Conditional-selex
|
|
IL147902A0
(en)
*
|
1999-08-12 |
2002-08-14 |
Agensys Inc |
C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
|
|
US20020009466A1
(en)
*
|
1999-08-31 |
2002-01-24 |
David J. Brayden |
Oral vaccine compositions
|
|
US7429639B2
(en)
*
|
1999-09-29 |
2008-09-30 |
Ludwig Institute For Cancer Research |
SSX-2 peptides presented by HLA class II molecules
|
|
AU6132700A
(en)
|
1999-09-30 |
2001-04-05 |
Chienna B.V. |
Polymers loaded with bioactive agents
|
|
US6790631B1
(en)
|
1999-10-05 |
2004-09-14 |
Agensys, Inc. |
G protein-coupled receptor up-regulated in prostate cancer and uses thereof
|
|
US7030228B1
(en)
*
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
|
AU2463701A
(en)
|
1999-12-29 |
2001-07-09 |
Nanodelivery, Inc. |
Drug delivery system exhibiting permeability control
|
|
JP2004501340A
(ja)
|
2000-01-13 |
2004-01-15 |
ナノスフェアー インコーポレイテッド |
オリゴヌクレオチドを付着させたナノ粒子とその使用方法
|
|
US8202979B2
(en)
|
2002-02-20 |
2012-06-19 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid
|
|
US20050020525A1
(en)
*
|
2002-02-20 |
2005-01-27 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
|
|
US20050032733A1
(en)
*
|
2001-05-18 |
2005-02-10 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SiNA)
|
|
US7534417B2
(en)
|
2000-02-24 |
2009-05-19 |
Agensys, Inc. |
103P2D6: tissue specific protein highly expressed in various cancers
|
|
SE0000933D0
(sv)
|
2000-03-21 |
2000-03-21 |
Independent Pharmaceutica Ab |
Method of producing 6-substituted (S)-nicotine derivatives and intermediate compounds
|
|
EP1309726B2
(en)
*
|
2000-03-30 |
2018-10-03 |
Whitehead Institute For Biomedical Research |
Rna sequence-specific mediators of rna interference
|
|
US7217770B2
(en)
|
2000-05-17 |
2007-05-15 |
Samyang Corporation |
Stable polymeric micelle-type drug composition and method for the preparation thereof
|
|
US6610713B2
(en)
|
2000-05-23 |
2003-08-26 |
North Shore - Long Island Jewish Research Institute |
Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
|
|
US20020151004A1
(en)
|
2000-07-24 |
2002-10-17 |
Roger Craig |
Delivery vehicles and methods for using the same
|
|
US6838484B2
(en)
*
|
2000-08-24 |
2005-01-04 |
University Of Tennessee Research Foundation |
Formulations comprising selective androgen receptor modulators
|
|
US7026500B2
(en)
*
|
2000-08-24 |
2006-04-11 |
University Of Tennessee Research Foundation |
Halogenated selective androgen receptor modulators and methods of use thereof
|
|
US6998500B2
(en)
*
|
2000-08-24 |
2006-02-14 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
|
AU2001285230C1
(en)
*
|
2000-08-24 |
2008-03-13 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
|
IL154425A0
(en)
|
2000-08-24 |
2003-09-17 |
Univ Tennessee Res H Corp |
Selective androgen receptor modulators and methods of use thereof
|
|
US20030232792A1
(en)
|
2000-08-24 |
2003-12-18 |
Dalton James T. |
Selective androgen receptor modulators and methods of use thereof
|
|
US20020173495A1
(en)
|
2000-08-24 |
2002-11-21 |
Dalton James T. |
Selective androgen receptor modulators and methods of use thereof
|
|
US20040260108A1
(en)
|
2001-06-25 |
2004-12-23 |
Dalton James T. |
Metabolites of selective androgen receptor modulators and methods of use thereof
|
|
US6503538B1
(en)
|
2000-08-30 |
2003-01-07 |
Cornell Research Foundation, Inc. |
Elastomeric functional biodegradable copolyester amides and copolyester urethanes
|
|
US6376190B1
(en)
*
|
2000-09-22 |
2002-04-23 |
Somalogic, Inc. |
Modified SELEX processes without purified protein
|
|
US20040067196A1
(en)
|
2000-10-11 |
2004-04-08 |
Brunke Karen J. |
Targeted therapeutic lipid constructs
|
|
US6589562B1
(en)
|
2000-10-25 |
2003-07-08 |
Salvona L.L.C. |
Multicomponent biodegradable bioadhesive controlled release system for oral care products
|
|
RU2322500C2
(ru)
|
2000-12-01 |
2008-04-20 |
Макс-Планк-Гезелльшафт Цур Фердерунг Дер Виссеншафтен Е.Ф. |
Малые молекулы рнк, опосредующие интерференцию рнк
|
|
US6623761B2
(en)
|
2000-12-22 |
2003-09-23 |
Hassan Emadeldin M. |
Method of making nanoparticles of substantially water insoluble materials
|
|
TWI246524B
(en)
|
2001-01-19 |
2006-01-01 |
Shearwater Corp |
Multi-arm block copolymers as drug delivery vehicles
|
|
CA2436408A1
(en)
|
2001-02-07 |
2002-12-12 |
Beth Israel Deaconess Medical Center |
Modified psma ligands and uses related thereto
|
|
US7097837B2
(en)
|
2001-02-19 |
2006-08-29 |
Pharmexa A/S |
Synthetic vaccine agents
|
|
US7326564B2
(en)
|
2001-02-20 |
2008-02-05 |
St. Jude Medical, Inc. |
Flow system for medical device evaluation and production
|
|
ES2234723T3
(es)
|
2001-03-22 |
2005-07-01 |
Cognis Iberia, S.L. |
Nanocapsulas.
|
|
WO2002076469A1
(en)
|
2001-03-27 |
2002-10-03 |
Baylor College Of Medicine |
A novel technology of intracellular delivery of dna oligonucleotides to improve drug activity
|
|
US20030175950A1
(en)
|
2001-05-29 |
2003-09-18 |
Mcswiggen James A. |
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
|
|
JP2006512401A
(ja)
|
2001-06-05 |
2006-04-13 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
ナノエマルジョンワクチン
|
|
DK1264603T3
(da)
|
2001-06-10 |
2010-04-26 |
Noxxon Pharma Ag |
Anvendelse af L-polynukleotider til in vivo-billeddannelse
|
|
US20030022868A1
(en)
*
|
2001-06-25 |
2003-01-30 |
Dalton James T. |
Selective androgen receptor modulators and methods of use thereof
|
|
AU2775402A
(en)
*
|
2001-06-29 |
2003-01-02 |
Medimolecular Pty Ltd |
Nucleic acid ligands to complex targets
|
|
JP4088251B2
(ja)
|
2001-07-02 |
2008-05-21 |
オリエンタル酵母工業株式会社 |
ニコチンアミドアデニンジヌクレオチドリン酸（ｎａｄｐ）の製造方法
|
|
BR0103887C1
(pt)
|
2001-07-17 |
2005-11-08 |
Univ Minas Gerais |
Composições imunogênicas contendo microesferas biodegradáveis encapsulando antìgenos, vetores gênicos e adjuvantes
|
|
EP1279404A1
(en)
|
2001-07-26 |
2003-01-29 |
Istituto Superiore di Sanità |
Use of HIV-1 tat, fragments or derivatives thereof, to target or to activate antigen-presenting cells, to deliver cargo molecules for vaccination or to treat other diseases
|
|
JP4607452B2
(ja)
|
2001-08-07 |
2011-01-05 |
ダイナバックス テクノロジーズ コーポレイション |
免疫調節性組成物、製剤およびその使用方法
|
|
CN100445395C
(zh)
|
2001-08-16 |
2008-12-24 |
诺弗姆公司 |
发酵方法
|
|
US20060004042A1
(en)
*
|
2001-08-23 |
2006-01-05 |
Dalton James T |
Formulations comprising selective androgen receptor modulators
|
|
WO2003020797A1
(en)
|
2001-08-30 |
2003-03-13 |
The Regents Of The University Of California |
Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
|
|
ATE447967T1
(de)
|
2001-09-14 |
2009-11-15 |
Cytos Biotechnology Ag |
Verpackung von immunstimulierendem cpg in virusähnlichen partikeln: herstellungsverfahren und verwendung
|
|
WO2003028657A2
(en)
|
2001-10-03 |
2003-04-10 |
The Johns Hopkins University |
Compositions for oral gene therapy and methods of using same
|
|
US20030134810A1
(en)
|
2001-10-09 |
2003-07-17 |
Chris Springate |
Methods and compositions comprising biocompatible materials useful for the administration of therapeutic agents
|
|
CN100518828C
(zh)
|
2001-10-10 |
2009-07-29 |
皮埃尔法布雷医药公司 |
缓释可生物降解微球体及其制备方法
|
|
WO2003033592A1
(en)
|
2001-10-18 |
2003-04-24 |
Samyang Corporation |
Polymeric micelle composition with improved stability
|
|
JP4425536B2
(ja)
|
2001-10-30 |
2010-03-03 |
株式会社吉野工業所 |
容器とその熱成形装置および熱成形方法
|
|
US20050064027A1
(en)
|
2001-12-15 |
2005-03-24 |
Spherics, Inc. |
Bioadhesive drug delivery system with enhanced gastric retention
|
|
US20030235619A1
(en)
|
2001-12-21 |
2003-12-25 |
Christine Allen |
Polymer-lipid delivery vehicles
|
|
WO2003057670A2
(en)
*
|
2001-12-28 |
2003-07-17 |
Guilford Pharmaceuticals Inc. |
Indoles as naaladase inhibitors
|
|
WO2003060523A1
(en)
|
2002-01-10 |
2003-07-24 |
Johns Hopkins University |
Imaging agents and methods of imaging naaladase of psma
|
|
US6720008B2
(en)
|
2002-01-22 |
2004-04-13 |
Pr Pharmaceuticals, Inc. |
Composition and method for the encapsulation of water-soluble molecules into nanoparticles
|
|
US8088388B2
(en)
|
2002-02-14 |
2012-01-03 |
United Biomedical, Inc. |
Stabilized synthetic immunogen delivery system
|
|
AU2003239121A1
(en)
|
2002-02-22 |
2003-09-09 |
Insert Therapeutics, Inc. |
Carbohydrate-modified polymers, compositions and uses related thereto
|
|
US20030232013A1
(en)
|
2002-02-22 |
2003-12-18 |
Gary Sieckman |
Therapeutic and diagnostic targeting of cancers cells with tumor homing peptides
|
|
US20040147489A1
(en)
|
2002-02-28 |
2004-07-29 |
Dalton James T. |
Haloacetamide and azide substituted compounds and methods of use thereof
|
|
ATE533494T1
(de)
|
2002-02-28 |
2011-12-15 |
Univ Tennessee Res Foundation |
Mehrfach substituierte selektive androgen- rezeptor-modulatoren und anwendungsverfahren dafür
|
|
WO2003074450A2
(en)
*
|
2002-02-28 |
2003-09-12 |
The University Of Tennessee Research Corporation |
Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
|
|
US7803970B2
(en)
*
|
2002-02-28 |
2010-09-28 |
University Of Tennessee Research Foundation |
Multi-substitued selective androgen receptor modulators and methods of use thereof
|
|
WO2003074679A2
(en)
|
2002-03-01 |
2003-09-12 |
Xencor |
Antibody optimization
|
|
WO2003086369A2
(en)
|
2002-04-05 |
2003-10-23 |
Valorisation-Recherche, Societe En Commandite |
Stealthy polymeric biodegradable nanospheres and uses thereof
|
|
US7285289B2
(en)
*
|
2002-04-12 |
2007-10-23 |
Nagy Jon O |
Nanoparticle vaccines
|
|
CN100419426C
(zh)
*
|
2002-04-22 |
2008-09-17 |
佛罗里达州立大学 |
功能化纳米微粒及其使用方法
|
|
JP2003342168A
(ja)
|
2002-05-24 |
2003-12-03 |
Nano Career Kk |
注射用薬物含有ポリマーミセル製剤の製造方法
|
|
US6819165B2
(en)
|
2002-05-30 |
2004-11-16 |
Analog Devices, Inc. |
Voltage regulator with dynamically boosted bias current
|
|
US20050214378A1
(en)
|
2002-06-11 |
2005-09-29 |
Ethypharm |
Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s)
|
|
US7741371B2
(en)
|
2002-06-17 |
2010-06-22 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
|
CN100537520C
(zh)
*
|
2002-06-17 |
2009-09-09 |
田纳西大学研究基金会 |
N-桥连选择性雄激素受体调节剂及其使用方法
|
|
US7767803B2
(en)
|
2002-06-18 |
2010-08-03 |
Archemix Corp. |
Stabilized aptamers to PSMA and their use as prostate cancer therapeutics
|
|
WO2003105780A2
(en)
*
|
2002-06-18 |
2003-12-24 |
Epigenesis Pharmaceuticals, Inc. |
A dry powder oligonucleotide formulation, preparation and its uses
|
|
CA2487809A1
(en)
|
2002-06-18 |
2003-12-24 |
Archemix Corp. |
Aptamer-toxin molecules and methods for using same
|
|
EP2392345A3
(en)
|
2002-07-18 |
2012-03-07 |
Cytos Biotechnology AG |
Hapten-carrier conjugates comprising virus like particles and uses thereof
|
|
DK1545597T3
(da)
|
2002-08-15 |
2011-01-31 |
3M Innovative Properties Co |
Immunstimulerende sammensætninger og fremgangsmåde til stimulering af en immunrespons
|
|
US6875605B1
(en)
|
2002-08-21 |
2005-04-05 |
Florida State University Research Foundation, Inc. |
Modular cell culture bioreactor and associated methods
|
|
US7488792B2
(en)
*
|
2002-08-28 |
2009-02-10 |
Burnham Institute For Medical Research |
Collagen-binding molecules that selectively home to tumor vasculature and methods of using same
|
|
EP1556506A1
(en)
|
2002-09-19 |
2005-07-27 |
The Chancellor, Masters And Scholars Of The University Of Oxford |
Molecular arrays and single molecule detection
|
|
US7008411B1
(en)
*
|
2002-09-30 |
2006-03-07 |
Advanced Cardiovascular Systems, Inc. |
Method and apparatus for treating vulnerable plaque
|
|
AU2003287077B2
(en)
|
2002-10-15 |
2007-09-20 |
University Of Tennessee Research Foundation |
Methylene-bridged selective androgen receptor modulators and methods of use thereof
|
|
US20040087810A1
(en)
*
|
2002-10-23 |
2004-05-06 |
Dalton James T. |
Irreversible selective androgen receptor modulators and methods of use thereof
|
|
EP2572715A1
(en)
|
2002-12-30 |
2013-03-27 |
3M Innovative Properties Company |
Immunostimulatory Combinations
|
|
PT1592658E
(pt)
|
2003-01-13 |
2013-06-25 |
Univ Tennessee Res Foundation |
Síntese em larga escala de modulador selectivo de receptor de androgénio
|
|
US20040156846A1
(en)
|
2003-02-06 |
2004-08-12 |
Triton Biosystems, Inc. |
Therapy via targeted delivery of nanoscale particles using L6 antibodies
|
|
JP2006517974A
(ja)
|
2003-02-13 |
2006-08-03 |
スリーエム イノベイティブ プロパティズ カンパニー |
Ｉｒｍ化合物およびトル様受容体８に関する方法および組成物
|
|
ATE371437T1
(de)
|
2003-02-17 |
2007-09-15 |
Peter Burkhard |
Peptidische nanoteilchen als arzneimittelabgabe- und antigen-display-systeme
|
|
US20040167103A1
(en)
|
2003-02-24 |
2004-08-26 |
Dalton James T. |
Haloacetamide and azide substituted compounds and methods of use thereof
|
|
US7871607B2
(en)
|
2003-03-05 |
2011-01-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
|
|
KR20060015534A
(ko)
|
2003-04-25 |
2006-02-17 |
더 펜 스테이트 리서치 파운데이션 |
성장 억제, 지질 유래된 생활성 화합물의 전신 전달을 위한방법 및 시스템
|
|
US20050008572A1
(en)
|
2003-04-29 |
2005-01-13 |
Ales Prokop |
Nanoparticular tumor targeting and therapy
|
|
US7731967B2
(en)
|
2003-04-30 |
2010-06-08 |
Novartis Vaccines And Diagnostics, Inc. |
Compositions for inducing immune responses
|
|
WO2004103159A2
(en)
|
2003-05-14 |
2004-12-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for modulating endometrium
|
|
GB0312309D0
(en)
|
2003-05-29 |
2003-07-02 |
Gaslini Children S Hospital G |
Targeted liposome
|
|
US20060239907A1
(en)
|
2003-06-03 |
2006-10-26 |
The Trustees Of The University Of Pennsylvania |
Stealthy nano agents
|
|
US7727969B2
(en)
|
2003-06-06 |
2010-06-01 |
Massachusetts Institute Of Technology |
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
|
|
US7149574B2
(en)
|
2003-06-09 |
2006-12-12 |
Palo Alto Investors |
Treatment of conditions through electrical modulation of the autonomic nervous system
|
|
MXPA05013973A
(es)
|
2003-06-17 |
2006-03-02 |
Mannkind Corp |
Metodos para producir, mejorar y sustentar respuestas inmunes contra epitopes restringidos mhc clase i, para propositos profilacticos o terapeuticos.
|
|
US20050031579A1
(en)
|
2003-06-30 |
2005-02-10 |
Canji, Inc. |
Polymer encapsulation of adenoviruses
|
|
US20050256071A1
(en)
|
2003-07-15 |
2005-11-17 |
California Institute Of Technology |
Inhibitor nucleic acids
|
|
SG190613A1
(en)
|
2003-07-16 |
2013-06-28 |
Protiva Biotherapeutics Inc |
Lipid encapsulated interfering rna
|
|
US7362068B2
(en)
*
|
2003-07-23 |
2008-04-22 |
Asmo Co., Ltd. |
Closing member control system
|
|
CA2536360C
(en)
|
2003-08-28 |
2013-08-06 |
Celula, Inc. |
Methods and apparatus for sorting cells using an optical switch in a microfluidic channel network
|
|
AU2004269405A1
(en)
|
2003-09-02 |
2005-03-10 |
University Of North Carolina At Chapel Hill |
Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpopulations and in cryopreservation, culture and transplantation of cells
|
|
EP1670509A4
(en)
|
2003-09-03 |
2007-10-31 |
Dendritherapeutics Inc |
MULTIPLEX VACCINES
|
|
CN1852740B
(zh)
|
2003-09-17 |
2011-05-11 |
耐科塔医药公司 |
多支链聚合物的药物前体
|
|
JP2007514519A
(ja)
|
2003-10-20 |
2007-06-07 |
ウィリアム・マーシュ・ライス・ユニバーシティ |
ポリマー及び帯電ナノ粒子からなるマイクロカプセルを製造する方法
|
|
US8129506B2
(en)
|
2003-10-24 |
2012-03-06 |
Genzyme Corporation |
Modulation of the interaction of MUC1 with MUC1 ligands
|
|
JP2007510160A
(ja)
|
2003-10-28 |
2007-04-19 |
アリックス インコーポレイテッド |
ホログラフィック光トラッピングを用いて物質を操作し、処理するためのシステム及び方法
|
|
US20070116768A1
(en)
|
2003-12-09 |
2007-05-24 |
Michael Chorny |
Sustained release preparations composed of biocompatible complex microparticles
|
|
KR101281775B1
(ko)
*
|
2003-12-19 |
2013-07-15 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
소프트 또는 임프린트 리소그래피를 이용하여 분리된마이크로- 및 나노- 구조를 제작하는 방법
|
|
US7846412B2
(en)
|
2003-12-22 |
2010-12-07 |
Emory University |
Bioconjugated nanostructures, methods of fabrication thereof, and methods of use thereof
|
|
US7335744B2
(en)
|
2003-12-23 |
2008-02-26 |
The Regents Of The California University |
Prostate cancer specific internalizing human antibodies
|
|
WO2005065418A2
(en)
|
2003-12-31 |
2005-07-21 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides for diagnosis and therapy
|
|
US8957034B2
(en)
|
2004-01-28 |
2015-02-17 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
|
US20070053845A1
(en)
|
2004-03-02 |
2007-03-08 |
Shiladitya Sengupta |
Nanocell drug delivery system
|
|
EP1729741A2
(en)
|
2004-03-03 |
2006-12-13 |
Spherics, Inc. |
Polymeric drug delivery system for hydrophobic drugs
|
|
WO2005110438A2
(en)
|
2004-04-15 |
2005-11-24 |
Massachusetts Institute Of Technology |
Methods and products related to the intracellular delivery of polysaccharides
|
|
WO2006078278A2
(en)
|
2004-04-27 |
2006-07-27 |
Alnylam Pharmaceuticals, Inc. |
Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety
|
|
ES2246695B1
(es)
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
|
|
EP1758558B1
(en)
|
2004-05-12 |
2013-10-16 |
Baxter International Inc. |
Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
|
|
US8821859B2
(en)
|
2004-05-19 |
2014-09-02 |
Agency For Science, Technology And Research |
Methods and articles for the delivery of therapeutic agents
|
|
CN100475837C
(zh)
|
2004-06-11 |
2009-04-08 |
北京键凯科技有限公司 |
多叉分支的聚乙二醇-氨基酸寡肽及其活性衍生物和药物结合物
|
|
WO2006002365A2
(en)
|
2004-06-24 |
2006-01-05 |
Angiotech International Ag |
Microparticles with high loadings of a bioactive agent
|
|
EP1768692B8
(en)
|
2004-07-01 |
2015-06-17 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
|
US20060258628A1
(en)
|
2004-07-20 |
2006-11-16 |
Steiner Mitchell S |
Compositions comprising 5-alpha reductase inhibitors, and SARMs and methods of use thereof
|
|
US20060062787A1
(en)
|
2004-07-22 |
2006-03-23 |
Genentech, Inc. |
Method for treating Sjogren's syndrome
|
|
KR100604976B1
(ko)
|
2004-09-03 |
2006-07-28 |
학교법인연세대학교 |
다작용기 리간드로 안정화된 수용성 나노입자
|
|
JP4833215B2
(ja)
|
2004-09-22 |
2011-12-07 |
ミリポア・コーポレイション |
少なくとも一つのトレー状揺動プラットフォームを含むバイオリアクタアセンブリ
|
|
JP5117191B2
(ja)
|
2004-10-01 |
2013-01-09 |
ミダテック リミテッド |
抗原及びアジュバントを含むナノ粒子、並びに免疫原性構造
|
|
WO2006042146A2
(en)
|
2004-10-07 |
2006-04-20 |
Emory University |
Multifunctional nanoparticles conjugates and their use
|
|
US9492400B2
(en)
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
|
BRPI0517837A
(pt)
|
2004-11-12 |
2008-10-21 |
Xencor Inc |
variantes fc com ligação alterada a fcrn
|
|
US20060111271A1
(en)
|
2004-11-24 |
2006-05-25 |
Cerny Erich H |
Active and passive immunization against pharmacologically active hapten molecules using a synthetic carrier compound composed of similar elements
|
|
US7361752B2
(en)
|
2004-12-14 |
2008-04-22 |
Alnylam Pharmaceuticals, Inc. |
RNAi modulation of MLL-AF4 and uses thereof
|
|
WO2006090924A1
(ja)
|
2005-02-28 |
2006-08-31 |
The University Of Tokyo |
ペプチドリガンドを有するブロック共重合体
|
|
WO2006093991A1
(en)
|
2005-03-02 |
2006-09-08 |
The Cleveland Clinic Foundation |
Compounds which bind psma and uses thereof
|
|
WO2006096754A2
(en)
|
2005-03-07 |
2006-09-14 |
Archemix Corp. |
Stabilized aptamers to psma and their use as prostate cancer therapeutics
|
|
US20070065359A1
(en)
|
2005-03-14 |
2007-03-22 |
Shiladitya Sengupta |
Nanocells for diagnosis and treatment of diseases and disorders
|
|
ES2396240T3
(es)
|
2005-04-20 |
2013-02-20 |
Mitsuru Akashi |
Poliaminoácido para usar como adyuvante
|
|
CA2607185A1
(en)
|
2005-05-04 |
2006-11-09 |
Noxxon Pharma Ag |
Intracellular active agents
|
|
US8088908B2
(en)
|
2005-05-10 |
2012-01-03 |
City Of Hope |
Humanized anti-prostate stem cell antigen monoclonal antibody
|
|
US20090304803A1
(en)
|
2005-06-06 |
2009-12-10 |
The General Hospital Corporation |
Compositions and methods relating to target-specific photodynamic therapy
|
|
US8728493B2
(en)
|
2005-06-17 |
2014-05-20 |
Nektar Therapeutics |
Polymer based compositions and conjugates of non-steroidal anti-inflammatory drugs
|
|
WO2007008994A2
(en)
|
2005-07-11 |
2007-01-18 |
Wyeth |
Glutamate aggrecanase inhibitors
|
|
EP1915449B1
(en)
|
2005-08-17 |
2016-03-23 |
Bioneer Corporation |
Sirna-hydrophilic polymer conjugates for intracellular delivery of sirna and method thereof
|
|
JPWO2007024026A1
(ja)
|
2005-08-25 |
2009-03-05 |
明石 満 |
Ｔ細胞認識エピトープペプチドを固定化又は内包化した生分解性ナノ粒子
|
|
JP2009508936A
(ja)
|
2005-09-20 |
2009-03-05 |
イッサム リサーチ ディベロップメント カンパニー |
活性物質の標的化送達用ナノ粒子
|
|
EP1973608A1
(en)
|
2005-12-14 |
2008-10-01 |
Cytos Biotechnology AG |
Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
|
|
US9267937B2
(en)
|
2005-12-15 |
2016-02-23 |
Massachusetts Institute Of Technology |
System for screening particles
|
|
JP2009520040A
(ja)
|
2005-12-19 |
2009-05-21 |
ファーマイン コーポレーション |
治療薬の送達のための疎水性コアの担体組成物、及び同担体組成物の作製法及び使用法
|
|
US20070233534A1
(en)
|
2006-01-06 |
2007-10-04 |
Marware Inc. |
Project management system and method
|
|
JP2009523823A
(ja)
|
2006-01-23 |
2009-06-25 |
アボット・ラボラトリーズ |
ｓｉＲＮＡ送達のための化学的に修飾されたポリカチオンポリマー
|
|
US8021689B2
(en)
|
2006-02-21 |
2011-09-20 |
Ecole Polytechnique Federale de Lausanne (“EPFL”) |
Nanoparticles for immunotherapy
|
|
WO2007109364A2
(en)
|
2006-03-20 |
2007-09-27 |
The General Hospital Corporation |
Intramolecularly quenched fluorochrome conjugates and methods of use
|
|
US20070225213A1
(en)
|
2006-03-23 |
2007-09-27 |
Kosak Matthew K |
Nucleic acid carriers for delivery of therapeutic agents
|
|
WO2008105773A2
(en)
|
2006-03-31 |
2008-09-04 |
Massachusetts Institute Of Technology |
System for targeted delivery of therapeutic agents
|
|
EP2018186A2
(en)
|
2006-04-11 |
2009-01-28 |
Ordway Research Institute, Inc. |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
|
|
US20100247653A1
(en)
|
2006-04-11 |
2010-09-30 |
Hans Lautenschlager |
Nanoparticles containing nicotine and/or cotinine, dispersions, and use thereof
|
|
JP5630998B2
(ja)
*
|
2006-05-15 |
2014-11-26 |
マサチューセッツ インスティテュート オブ テクノロジー |
機能的粒子のためのポリマー
|
|
US20110052697A1
(en)
|
2006-05-17 |
2011-03-03 |
Gwangju Institute Of Science & Technology |
Aptamer-Directed Drug Delivery
|
|
CN101467235A
(zh)
|
2006-06-13 |
2009-06-24 |
Nxp股份有限公司 |
双栅极晶体管及其制造方法
|
|
WO2007150030A2
(en)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
|
US20090117549A1
(en)
*
|
2006-07-18 |
2009-05-07 |
Weihong Tan |
Aptamer-based methods for identifying cellular biomarkers
|
|
US20100144845A1
(en)
|
2006-08-04 |
2010-06-10 |
Massachusetts Institute Of Technology |
Oligonucleotide systems for targeted intracellular delivery
|
|
US20080171059A1
(en)
|
2006-08-07 |
2008-07-17 |
Shanshan Wu Howland |
Methods and compositions for increased priming of t-cells through cross-presentation of exogenous antigens
|
|
US20080057102A1
(en)
|
2006-08-21 |
2008-03-06 |
Wouter Roorda |
Methods of manufacturing medical devices for controlled drug release
|
|
US20080078921A1
(en)
|
2006-08-25 |
2008-04-03 |
Motorola, Inc. |
Multiple light sensors and algorithms for luminance control of mobile display devices
|
|
JPWO2008041703A1
(ja)
|
2006-10-02 |
2010-02-04 |
国立大学法人大阪大学 |
インフルエンザワクチン用アジュバントおよびインフルエンザワクチン
|
|
PT3699162T
(pt)
|
2006-11-08 |
2022-10-11 |
Molecular Insight Pharm Inc |
Heterodímeros de ácido glutâmico
|
|
WO2008147456A2
(en)
|
2006-11-20 |
2008-12-04 |
Massachusetts Institute Of Technology |
Drug delivery systems using fc fragments
|
|
US20080213377A1
(en)
|
2006-12-08 |
2008-09-04 |
Bhatia Sangeeta N |
Delivery of Nanoparticles and/or Agents to Cells
|
|
US9217129B2
(en)
|
2007-02-09 |
2015-12-22 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
|
WO2008124639A2
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Poly (amino acid) targeting moieties
|
|
WO2008124634A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
|
US20080299177A1
(en)
|
2007-06-06 |
2008-12-04 |
Biovaluation & Analysis, Inc. |
Supramolecular Complexes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo
|
|
ES2376175T3
(es)
|
2007-09-28 |
2012-03-09 |
Bind Biosciences, Inc. |
Direccionamiento a células de c�?ncer usando nanopart�?culas.
|
|
BRPI0817664A2
(pt)
|
2007-10-12 |
2015-03-24 |
Massachusetts Inst Technology |
Nanopartículas, método para preparar nanopartículas e método para tratar terapeuticamente ou profilaticamente um indivíduo
|
|
RU2540871C2
(ru)
|
2008-02-01 |
2015-02-10 |
Альфа-О Пептидес Аг |
Самоорганизующиеся пептидные наночастицы, полезные в качестве вакцин
|
|
EP2106806A1
(en)
|
2008-03-31 |
2009-10-07 |
Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V. |
Nanoparticles for targeted delivery of active agents to the lung
|
|
WO2010005726A2
(en)
|
2008-06-16 |
2010-01-14 |
Bind Biosciences Inc. |
Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
|
|
EP2309991B1
(en)
|
2008-06-16 |
2019-03-06 |
Pfizer Inc |
Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same
|
|
JP2012501965A
(ja)
|
2008-06-16 |
2012-01-26 |
バインド バイオサイエンシズ インコーポレイテッド |
薬剤を装填したポリマーナノ粒子及びその製造方法と使用方法
|
|
US8277812B2
(en)
*
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
|
US8343498B2
(en)
*
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
|
US8591905B2
(en)
*
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
|
US8343497B2
(en)
*
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
|
US8563041B2
(en)
|
2008-12-12 |
2013-10-22 |
Bind Therapeutics, Inc. |
Therapeutic particles suitable for parenteral administration and methods of making and using same
|
|
EP2379064B1
(en)
|
2008-12-15 |
2020-02-26 |
Pfizer Inc. |
Long circulating nanoparticles for sustained release of therapeutic agents
|
|
WO2010114768A1
(en)
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-epothilone conjugates, particles, compositions, and related methods of use
|
|
WO2010114770A1
(en)
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
|
WO2011072218A2
(en)
|
2009-12-11 |
2011-06-16 |
Bind Biosciences |
Stable formulations for lyophilizing therapeutic particles
|
|
MX2014003280A
(es)
|
2011-09-20 |
2014-05-13 |
Procter & Gamble |
Composiciones detergentes que comprenden sistemas surfactantes sostenibles que comprenden surfactantes derivados de isoprenoides.
|